Streetbeat News

Earnings

ALPN

Alpine Immune Sciences (NASDAQ:ALPN) reported Q4 2023 earnings of $0.15 per share, surpassing the $(0.29) estimate, with sales of $30.853M beating the $9.104M estimate, marking a 1.01K% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:48 pm

DOW

Benzinga's options scanner revealed significant activity in Dow (NYSE:DOW) options, with over 11 transactions totaling $427,337. Analysis of trading volumes and open interest suggests a focus on a price range between $52.5 and $60.0. Notable options activity includes both bearish and bullish sentiments on calls and puts. Dow Chemical, a major chemicals producer, is currently trading at $56.74, down by -0.53%, with an RSI indicating a potential approach to overbought territory. The anticipated earnings release is in 38 days.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 8:45 pm

CMTL

Comtech Telecommunications (CMTL) reports challenging business conditions and an unpredictable operating environment as it enters Q3 of fiscal 2024. Despite these challenges, the company is making progress through its One Comtech transformation, aiming for net sales and Adjusted EBITDA in FY24 to surpass FY23's figures. This comes after reporting positive GAAP operating income for three consecutive fiscal quarters since 2021.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:44 pm

CMTL

Comtech Telecom (NASDAQ:CMTL) reported Q2 adjusted EPS of $(0.15), missing the $0.22 estimate, and sales of $134.22M, missing the $152.85M estimate. This represents a significant decrease in earnings and a slight increase in sales compared to the same period last year.

Portfolio Pulse from Happy Mohamed

March 18, 2024 | 8:41 pm

PRSO

Peraso (NASDAQ:PRSO) reported Q4 earnings with an EPS of $-8.52, missing estimates by -127.0% and a revenue decrease of $2.06 million year-over-year. This follows a pattern of mixed past earnings performance, with the company previously beating and missing EPS estimates.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 8:40 pm

OMIC

Singular Genomics Systems (NASDAQ:OMIC) reported Q4 earnings, beating estimates with an EPS of $-0.32 against an expected $-0.34 and saw a revenue increase of $316 thousand year-over-year. The company has a history of surpassing EPS estimates, which previously led to a 7% stock price increase the following day.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 8:40 pm

OMIC

Singular Genomics Systems (OMIC) reported Q4 2023 earnings with a GAAP EPS of $(0.32), surpassing the $(0.36) estimate. Sales reached $1.081M, exceeding the $731.333K forecast, marking a 41.31% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:38 pm

PRSO

Peraso (NASDAQ:PRSO) reported Q4 EPS of $(8.52), missing the $(3.76) estimate by 126.6%, and a 63.85% decrease from last year's $(5.20) per share. Sales were $1.83M, beating the $1.70M estimate by 7.76%, but down 52.87% from last year's $3.89M.

Portfolio Pulse from dijoy@benzinga.com

March 18, 2024 | 8:36 pm

NCMI

National CineMedia (NCMI) shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:33 pm

DRQ

Dril-Quip, Inc. (DRQ) and Innovex Downhole Solutions have agreed to merge in an all-stock transaction. Post-merger, DRQ stockholders will own about 52% and Innovex stockholders about 48% of the new entity. The deal is expected to be immediately accretive to earnings and free cash flow.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:32 pm